• EUD-GK-91 has succesfully reached PoC in NSCLC Tumour Cells


  • EUD-GK-91 shows a preferential and significant inhibition of the gatekeeper resistant mutation


  • EUD-GK-91 has a good selectivity profile with low effect on normal cells

  • Eudendron has developed novel molecular designs to generate compounds successfully inhibiting kinase mutated forms


  • EUD-GK-91 is a novel compound designed and prepared by Eudendron to provide an effective and promising answer to drug resistance in NSCLC treatment


Eudendron S.r.l.

Legal Office:

Via Dei Carantani,1 


21100 - ITALY


P.IVA: 03303730125 

C.F.: 03303730125

REA: VA-340127


T: +39 340 3665660

    +44 7918 928462

© 2012 by Eudendron Srl. 

No animals were harmed in the making of this site.

  • facebook
  • w-tbird
  • w-googleplus
This site was designed with the
website builder. Create your website today.
Start Now